Keywords: R&D investment, Europe, Sanofi-Aventis, Johnson & Johnson, Pfizer, Bayer

Despite economic crisis, top EU firms cut R&D investment less than US rivals, but Europe still behind; strong pharma showing

Article | 27 October 2010

Print This

The European Commission's 2010 "EU Industrial R&D Investment Scoreboard" shows that R&D investment by top European Union ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in